Literature DB >> 22108912

Lateral allosterism in the glucagon receptor family: glucagon-like peptide 1 induces G-protein-coupled receptor heteromer formation.

Dominik Schelshorn1, Fanny Joly, Sophie Mutel, Cornelia Hampe, Billy Breton, Vincent Mutel, Robert Lütjens.   

Abstract

Activation of G-protein-coupled receptors (GPCRs) results in a variety of cellular responses, such as binding to the same receptor of different ligands that activate distinct downstream cascades. Additional signaling complexity is achieved when two or more receptors are integrated into one signaling unit. Lateral receptor interactions can allosterically modulate the receptor response to a ligand, which creates a mechanism for tissue-specific fine tuning, depending on the cellular receptor coexpression pattern. GPCR homomers or heteromers have been explored widely for GPCR classes A and C but to lesser extent for class B. In the present study, we used bioluminescence resonance energy transfer (BRET) techniques, calcium flux measurements, and microscopy to study receptor interactions within the glucagon receptor family. We found basal BRET interactions for some of the receptor combinations tested that decreased upon ligand binding. A BRET increase was observed exclusively for the gastric inhibitory peptide (GIP) receptor and the glucagon-like peptide 1 (GLP-1) receptor upon binding of GLP-1 that could be reversed with GIP addition. The interactions of GLP-1 receptor and GIP receptor were characterized with BRET donor saturation studies, shift experiments, and tests of glucagon-like ligands. The heteromer displayed specific pharmacological characteristics with respect to GLP-1-induced β-arrestin recruitment and calcium flux, which suggests a form of allosteric regulation between the receptors. This study provides the first example of ligand-induced heteromer formation in GPCR class B. In the body, the receptors are functionally related and coexpressed in the same cells. The physiological evidence for this heteromerization remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108912     DOI: 10.1124/mol.111.074757

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  37 in total

Review 1.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

2.  GLP-1 receptor is expressed in human stomach mucosa: analysis of its cellular association and distribution within gastric glands.

Authors:  Efrat Broide; Olga Bloch; Gilad Ben-Yehudah; Dror Cantrell; Haim Shirin; Micha J Rapoport
Journal:  J Histochem Cytochem       Date:  2013-06-26       Impact factor: 2.479

Review 3.  G Protein-Coupled Receptor Heteromers.

Authors:  Ivone Gomes; Mohammed Akli Ayoub; Wakako Fujita; Werner C Jaeger; Kevin D G Pfleger; Lakshmi A Devi
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-22       Impact factor: 13.820

4.  Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic β cells.

Authors:  Ming Zhang; Mélanie Robitaille; Aaron D Showalter; Xinyi Huang; Ying Liu; Alpana Bhattacharjee; Francis S Willard; Junfeng Han; Sean Froese; Li Wei; Herbert Y Gaisano; Stéphane Angers; Kyle W Sloop; Feihan F Dai; Michael B Wheeler
Journal:  Mol Cell Proteomics       Date:  2014-07-20       Impact factor: 5.911

5.  Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking.

Authors:  Sarah Noerklit Roed; Anne Cathrine Nøhr; Pernille Wismann; Helle Iversen; Hans Bräuner-Osborne; Sanne Moeller Knudsen; Maria Waldhoer
Journal:  J Biol Chem       Date:  2014-12-01       Impact factor: 5.157

6.  Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery.

Authors:  Kaleeckal G Harikumar; Denise Wootten; Delia I Pinon; Cassandra Koole; Alicja M Ball; Sebastian G B Furness; Bim Graham; Maoqing Dong; Arthur Christopoulos; Laurence J Miller; Patrick M Sexton
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

7.  Pancreatic Beta Cell G-Protein Coupled Receptors and Second Messenger Interactions: A Systems Biology Computational Analysis.

Authors:  Leonid E Fridlyand; Louis H Philipson
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

8.  The identification of novel proteins that interact with the GLP-1 receptor and restrain its activity.

Authors:  X Huang; F F Dai; G Gaisano; K Giglou; J Han; M Zhang; S Kittanakom; V Wong; L Wei; A D Showalter; K W Sloop; I Stagljar; M B Wheeler
Journal:  Mol Endocrinol       Date:  2013-07-17

Review 9.  Minireview: Signal bias, allosterism, and polymorphic variation at the GLP-1R: implications for drug discovery.

Authors:  Cassandra Koole; Emilia E Savage; Arthur Christopoulos; Laurence J Miller; Patrick M Sexton; Denise Wootten
Journal:  Mol Endocrinol       Date:  2013-07-17

10.  N-glycan remodeling on glucagon receptor is an effector of nutrient sensing by the hexosamine biosynthesis pathway.

Authors:  Anita Johswich; Christine Longuet; Judy Pawling; Anas Abdel Rahman; Michael Ryczko; Daniel J Drucker; James W Dennis
Journal:  J Biol Chem       Date:  2014-04-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.